Constellation Pharmaceuticals - 48 Year Dividend History | CNST

Historical dividend payout and yield for Constellation Pharmaceuticals (CNST) since 1971. The current TTM dividend payout for Constellation Pharmaceuticals (CNST) as of June 14, 2019 is $0.00. The current dividend yield for Constellation Pharmaceuticals as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.233B $0.000B
Constellation Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. It discovers and develops molecule therapeutics for the treatment of cancer, inflammatory and immunologic disorders. The company's lead product candidates consists of CPI-1205, which inhibits enhancer of zeste homolog 2 and CPI-0610, which inhibits bromodomain and extra terminal domain. Constellation Pharmaceuticals, Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83